Company Filing History:
Years Active: 2012-2013
Title: Ryotaro Ibuka: Innovations in Pharmaceutical Compositions
Introduction:
Ryotaro Ibuka, a prominent inventor based in Tokyo, Japan, is known for his groundbreaking work in the field of pharmaceutical compositions. With a total of 2 patents to his name, Ibuka has made significant contributions to the medical industry.
Latest Patents:
1. Amide compound: Ibuka's invention of an amide compound with EP4 receptor antagonistic activity has paved the way for the development of pharmaceutical compositions aimed at treating chronic renal failure and diabetic nephropathy. This compound offers promising solutions for a range of EP4-related diseases.
2. Piperidine derivative or salt thereof: Ibuka's research led to the discovery of a novel piperidine derivative that shows excellent CaSR agonistic regulatory action. This compound holds potential as a therapeutic agent for diseases involving the calcium sensing receptor, such as hyperparathyroidism, renal osteodystrophy, and hypercalcemia.
Career Highlights:
Currently affiliated with Astellas Pharma GmbH, Ibuka plays a key role in driving innovation within the company. His expertise in pharmacology and drug development has positioned him as a thought leader in the field.
Collaborations:
Ibuka has had the privilege of working alongside accomplished colleagues such as Kazuhiro Ikegai and Ryushi Seo. Their collaborative efforts have resulted in the successful development of novel pharmaceutical compounds with significant clinical implications.
Conclusion:
In conclusion, Ryotaro Ibuka's dedication to advancing the field of pharmaceutical compositions has led to the creation of innovative solutions for complex medical conditions. His passion for innovation and commitment to scientific research continue to inspire future generations of inventors in the pursuit of medical advancements.